Validation period: 11/29/2022, 3:43:33 AM - 11/29/2022, 9:43:33 AM
BMJ Journals logo
Email alerts

Annals of the Rheumatic Diseases (ARD)

is a leading rheumatology journal from BMJ and EULAR, publishing original research, reviews and recommendations

Impact Factor: 28.003
Citescore: 28.5
All metrics >>

Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal covering all aspects of rheumatology, which includes the full spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research, including the most important recommendations for the management of various conditions.

ARD is an official journal of EULAR.

Free lay summaries are provided for selected research articles and all EULAR recommendations. You can keep up with the latest news via Twitter and Facebook.


Listen to the ARD podcast and subscribe in all podcast platforms, including Apple Podcast, Google Podcasts, Stitcher and Spotify

Editor-in-Chief: Professor Josef Smolen, Medical University of Vienna, Austria
Editorial team

ARD is a Plan S compliant Transformative Journal.

Current IssueJournal Current Issue

Key Articles from the last 75 years

Commentaries on key papers from 1997

Kimme Hyrich comments on the significance of papers published in the journal 25 years ago.


Annals of the Rheumatic Diseases considers unsolicited submissions of a variety of article types, including original research articles (extended and concise reports), viewpoints, and letters to the Editor.

The Author Information section provides general guidelines and requirements for specific article types.

Information is also provided on editorial policies and open access.

Author informationSubmit a paper

Editor's Choice


Isolated axial disease in psoriatic arthritis and ankylosing spondylitis with psoriasis

10 November 2022

Latest Articles

Articles by Topic


The EULAR Standing Committees regularly establish and publish recommendations for the treatment of various rheumatic disorders. Each of these recommendations is developed by a group of specialists in their field.

All EULAR recommendations are free to access.

Each recommendation also has an accompanying lay summary, which is also free to access.


Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axSpA

Ninety-six per cent of patients withdrawn to placebo recaptured at least ASDAS LDA and 71% recaptured ASDAS ID with IXE retreatment at week 104. This may provide support to patients who may require a brief interruption in therapy.

Find out more



View all doctor jobsRheumatology JobsGP JobsHospital Jobs
Hospice Physician

Burnley, Lancashire

Hospice Physician or Physicians required to join our established multi-disciplinary team. Working across all Hospice Clinical Services

Recruiter: Pendleside Hospice

Salaried GP or Partner

Oxford, Oxfordshire

Salaried or Partnership role required. 4 to 8 sessions per week. Flexible working opportunities.

Recruiter: Hollow Way Medical Centre

Consultant in Gastroenterology with interest in Hepatology

Jersey (GB) (JE)

The Island of Jersey is seeking a third consultant gastroenterologist. We are looking to appoint a dynamic-forward thinking consultant

Recruiter: Government of Jersey

Primary Care Medical Director (Part time/Fixed Term)

Brighton, East Sussex

Are you an experienced GP with leadership experience?

Recruiter: Integrated Care 24 Ltd

Salaried Remote GPs

Homeworking options throughout England, Scotland and Wales and clinics in London and Birmingham

Clinicians required to join this global care company. Option of flexible working, so you can work from home or at one of our clinics.

Recruiter: Babylon

eular-75 logoeular-textbooks logo
Website Terms & ConditionsPrivacy & CookiesContact BMJCookie settingsOnline ISSN: 1468-2060 Print ISSN: 0003-4967Copyright © 2022 BMJ Publishing Group Ltd & European Alliance of Associations for Rheumatism. All rights reserved.